Pervasis Therapeutics

About:

Pervasis Therapeutics is a clinical stage company offering a broad portfolio of biologically active therapeutics.

Website: http://www.pervasistx.com

Top Investors: Flagship Pioneering, Polaris Partners, Highland Capital Partners, Musket Research Associates

Description:

Pervasis Therapeutics is a clinical stage company developing a broad portfolio of biologically active therapeutics. Building on its deep understanding of the specialized role that the endothelium plays in regulating natural healing and repair processes associated with disease, Pervasis is advancing groundbreaking new therapies to dramatically improve the outcomes of common vascular interventions, such as arteriovenous access, angioplasties, stents, and peripheral and coronary bypass grafts – the failure of which result in serious complications and a significant increase in medical costs.

Total Funding Amount:

$42M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2003-01-01

Contact Email:

info(AT)pervasistx.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2009-08-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai